Synergistic therapeutics: Co-targeting histone deacetylases and ribonucleotide reductase for enhanced cancer treatment

Shetty, Manasa Gangadhar; Pai, Padmini; Padavu, Mythili; Satyamoorthy K.

dc.contributor.author	Shetty, Manasa Gangadhar
dc.contributor.author	Pai, Padmini
dc.contributor.author	Padavu, Mythili
dc.contributor.author	Satyamoorthy K.
dc.date.accessioned	2025-01-24T10:22:28Z
dc.date.available	2025-01-24T10:22:28Z
dc.date.issued	2024-04
dc.identifier.citation	European Journal of Medicinal Chemistry. 2024 April; 269(7): 16324-16341.	en_US
dc.identifier.issn	0223-5234
dc.identifier.uri	http://dspace.sdmucmsh.edu.in:8080/xmlui/handle/123456789/2400
dc.language.iso	en	en_US
dc.publisher	Elsevier	en_US
dc.subject	Anticancer	en_US
dc.subject	Combination therapy	en_US
dc.subject	Dual/multitargeting	en_US
dc.title	Synergistic therapeutics: Co-targeting histone deacetylases and ribonucleotide reductase for enhanced cancer treatment	en_US
dc.type	Article	en_US